Search Results - Oude Ophius, Ton

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

    Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction by Magnani, Giulia, Ardissino, Diego, Im, KyungAh, Budaj, Andrzej, Storey, Robert F, Steg, P Gabriel, Bhatt, Deepak L, Cohen, Marc, Oude Ophius, Ton, Goudev, Assen, Parkhomenko, Alexander, Kamensky, Gabriel, Angiolillo, Dominick J, López-Sendón, José, Johanson, Per, Braunwald, Eugene, Sabatine, Marc S, Bonaca, Marc P

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION

    THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUT... by Gibson, C. Michael, Yee, Megan, Daaboul, Yazan, Korjian, Serge, Mehr, Ali Poyan, Kerneis, Mathieu, Tricoci, Pierluigi, Alexander, John, Kastelein, John, Mehran, Roxana, Bode, Christoph, Lewis, Basil, Mehta, Ravindra, Duffy, Danielle, Feaster, John, Halabi, Majdi, Angiolillo, Dominick, Duerschmied, Daniel, Ophius, Ton Oude, Merkely, Bela

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascul... by Rao, Sunil V., Kirsch, Bodo, Bhatt, Deepak L., Budaj, Andrzej, Coppolecchia, Rosa, Eikelboom, John, James, Stefan K., Jones, W. Schuyler, Merkely, Bela, Keller, Lars, Hermanides, Renicus S., Campo, Gianluca, Ferreiro, José Luis, Shibasaki, Taro, Mundl, Hardi, Alexander, John H.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction

    Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolera... by Gibson, C. Michael, Korjian, Serge, Tricoci, Pierluigi, Daaboul, Yazan, Alexander, John H., Steg, Philippe G., Lincoff, A. Michael, Kastelein, John J.P., Mehran, Roxana, D'Andrea, Denise, Merkely, Bela, Zarebinski, Maciej, Ophius, Ton Oude, Harrington, Robert A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Rationale and Design of AEGIS-I: A Phase 2b, Randomized, Placebo-controlled, Dose-ranging Trial to Investigate the Safety and Tolerability of CSL112, a Reconstituted, Infusible, Human ApoA-I, After Acute Myocardial Infarction

    Rationale and Design of AEGIS-I: A Phase 2b, Randomized, Placebo-controlled, Dose-ranging Trial to Investigate the Safety and Tolerability of CSL112, a Reconstituted, Infusible, Hu... by Gibson, C. Michael, Korjian, Serge S, Tricoci, Pierluigi, Daaboul, Yazan S, Alexander, John H, Steg, Philippe G, Lincoff, A. Michael, Kastelein, John J.P, Mehran, Roxana, D'Andrea, Denise, Merkely, Bela, Zarebinski, Maciej, Ophius, Ton Oude, Harrington, Robert A

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: